ESI–MS studies of the reactions of novel platinum(II) complexes containing O,O′-chelated acetylacetonate and sulfur ligands with selected model proteins

[1]  A. Merlino,et al.  Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy. , 2017, Chemistry.

[2]  A. Casini,et al.  Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells. , 2016, Journal of inorganic biochemistry.

[3]  L. Messori,et al.  New gold carbene complexes as candidate anticancer agents , 2016, BioMetals.

[4]  G. Ferraro,et al.  The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c. , 2015, Chemical communications.

[5]  A. Merlino,et al.  Unusual structural features in the lysozyme derivative of the tetrakis(acetato)chloridodiruthenium(II,III) complex. , 2014, Angewandte Chemie.

[6]  F. Fornai,et al.  Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer , 2014, Cell Death and Disease.

[7]  A. Merlino,et al.  Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme. , 2013, Inorganic chemistry.

[8]  M. Bottone,et al.  Cisplatin-related drugs for nongenomic targets: Forcing the reactivity with nucleobases , 2012 .

[9]  J. Omichinski,et al.  The Organomercurial Lyase MerB , 2010 .

[10]  S. D. De Pascali,et al.  Hard/soft selectivity in ligand substitution reactions of beta-diketonate platinum(II) complexes. , 2009, Dalton transactions.

[11]  S. D. De Pascali,et al.  New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells. , 2007, Biochemical pharmacology.

[12]  A. Casini,et al.  Structural investigation of cisplatin-protein interactions: selective platination of His19 in a cuprozinc superoxide dismutase. , 2006, Angewandte Chemie.

[13]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[14]  P. Papadia,et al.  First Examples of β-Diketonate Platinum(II) Complexes with Sulfoxide Ligands , 2005 .